Mifepristone Clinical Trial
Official title:
Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency
The researchers propose the use of mifepristone as an alternative way to test for Central Adrenal Insufficiency (CAI). They want to assess the feasibility of recruitment and the efficacy of the purposed method.
Recruitment for this trial was legally opened on February 17, 2020. When the record was first released, it incorrectly listed the recruitment status as "Not Yet Recruiting." This mistake was noticed before the first participant actually enrolled, May 5, 2021. The decision to terminate for low recruitment was made on Sept 7, 2022, approximately 30 months later, as at that point it was deemed impossible to reach the initial enrollment target of 26. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03727308 -
Study of Clinic-based Versus Self-use of Medical Abortion Pills
|
||
| Recruiting |
NCT01636063 -
Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks
|
N/A | |
| Not yet recruiting |
NCT05151016 -
Long-term Use of Mifepristone in the Treatment of Adenomyosis
|
Early Phase 1 |